Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Human Corneal Epithelial Cells as an In Vitro Keratitis Cell Model
Restricted accessResearch articleFirst published online December, 2025
Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Human Corneal Epithelial Cells as an In Vitro Keratitis Cell Model
Inflammation and oxidative stress are principal contributors to the pathogenesis of numerous ocular conditions, including keratitis. Lipopolysaccharide (LPS)-induced corneal inflammation is a commonly used in vitro model to explore the anti-inflammatory and antioxidant potential of novel therapeutic agents.
Methods:
Human corneal epithelial cells (HCECs) were stimulated with LPS to reproduce an inflammatory microenvironment. Rosmarinic acid was administered at different concentrations, and its effects were evaluated using several endpoints. Cell viability was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Intracellular reactive oxygen species (ROS), pro-inflammatory cytokines (interleukin [IL]-6, IL-1β, tumor necrosis factor-α [TNF-α]), transforming growth factor-β (TGF-β), and nuclear factor erythroid 2-related factor 2 (Nrf2) and Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) were quantified at mRNA and protein levels.
Results:
Rosmarinic acid significantly restored cell viability, reduced ROS generation, and suppressed pro-inflammatory cytokine expression in a concentration-dependent manner. Furthermore, it modulated TGF-β expression and normalized NF-κB and Nrf2 levels suggesting a broader regulatory effect on inflammatory and repair mechanisms.
Conclusions:
These findings underscore the potent anti-inflammatory and antioxidative properties of rosmarinic acid in HCECs. Rosmarinic acid may represent a promising therapeutic avenue for the management of corneal inflammation and oxidative stress-induced ocular pathologies.
WongHL, PoonSHL, BuY, et al.A systematic review on cornea epithelial-stromal homeostasis. Ophthalmic Res, 2021; 64(2):178–191.
2.
WenL, ZhuM, MadiganMC, et al.Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells. PLoS One, 2014; 9(7):e101841.
3.
LiangH, Brignole-BaudouinF, LabbéA, et al.LPS-stimulated inflammation and apoptosis in corneal injury models. Mol Vis, 2007; 13:1169–1180.
4.
SchultzC, MorckD, McKayS, et al.Lipopolysaccharide induced acute red eye and corneal ulcers. Exp Eye Res, 1997; 64(1):3–9.
5.
WuL, DuL, JuQ, et al.Silencing TLR4/MyD88/NF-κB signaling pathway alleviated inflammation of corneal epithelial cells infected by ISE. Inflammation, 2021; 44(2):633–644.
6.
LiuR, LiJ, XuY, et al.Melatonin attenuates LPS-induced proinflammatory cytokine response and lipogenesis in human meibomian gland epithelial cells via MAPK/NF-κB pathway. Invest Ophthalmol Vis Sci, 2022; 63(5):6.
7.
YangL, ZhangS, DuanH, et al.Different effects of pro-inflammatory factors and hyperosmotic stress on corneal epithelial stem/progenitor cells and wound healing in mice. Stem Cells Transl Med, 2019; 8(1):46–57.
8.
ChenK, LiY, ZhangX, et al.The role of the PI3K/AKT signalling pathway in the corneal epithelium: Recent updates. Cell Death Dis, 2022; 13(5):513.
9.
LiZ-Y, ChenZ-L, ZhangT, et al.TGF-β and NF-κB signaling pathway crosstalk potentiates corneal epithelial senescence through an RNA stress response. Aging (Albany NY), 2016; 8(10):2337–2354.
10.
AngiolellaL, SacchettiG, EfferthT. Antimicrobial and antioxidant activities of natural compounds. Evidence-Based Complementary and Alternative Medicine: Ecam, 2018; 2018(1).
11.
ChagasM, BehrensMD, Moragas-TellisCJ, et al.Flavonols and flavones as potential anti‐inflammatory, antioxidant, and antibacterial compounds. Oxid Med Cell Longev, 2022; 2022(1):9966750.
12.
SadeghiA, BastinAR, GhahremaniH, et al.The effects of rosmarinic acid on oxidative stress parameters and inflammatory cytokines in lipopolysaccharide-induced peripheral blood mononuclear cells. Mol Biol Rep, 2020; 47(5):3557–3566.
13.
LuY-h, HongY, ZhangT-y, et al.Rosmarinic acid exerts anti-inflammatory effect and relieves oxidative stress via Nrf2 activation in carbon tetrachloride-induced liver damage. Food Nutr Res, 2022; 66:10.29219/fnr.v66.8359.
14.
ChenC-P, LinY-C, PengY-H, et al.Rosmarinic acid attenuates the lipopolysaccharide-provoked inflammatory response of vascular smooth muscle cell via inhibition of MAPK/NF-κB cascade. Pharmaceuticals (Basel), 2022; 15(4):437.
15.
WeiY, ChenJ, HuY, et al.Rosmarinic acid mitigates lipopolysaccharide-induced neuroinflammatory responses through the inhibition of TLR4 and CD14 expression and NF-κB and NLRP3 inflammasome activation. Inflammation, 2018; 41(2):732–740.
16.
SimYE, KimC-L, KimDH, et al.Rosmarinic acid promotes cartilage regeneration through Sox9 induction via NF-κB pathway inhibition in mouse osteoarthritis progression. Heliyon, 2024; 10(19):e38936.
17.
MaZ, LuY, YangF, et al.Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways. Toxicol Appl Pharmacol, 2020; 397:115014.
18.
QuanW, LiuH-X, ZhangW, et al.Cardioprotective effect of rosmarinic acid against myocardial ischaemia/reperfusion injury via suppression of the NF-κB inflammatory signalling pathway and ROS production in mice. Pharm Biol, 2021; 59(1):222–231.
19.
ZhangY, ChenX, YangL, et al.Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice. Food Funct, 2015; 6(3):927–931.
20.
WuL, YeM, ZhangJ. Vincamine prevents lipopolysaccharide induced inflammation and oxidative stress via thioredoxin reductase activation in human corneal epithelial cells. American Journal of Translational Research, 2018; 10(7):2195.
21.
OgataFT, VermaS, Coulson-ThomasVJ, et al.TGF-β-based therapies for treating ocular surface disorders. Cells, 2024; 13(13):1105.
22.
LorenzL, HirmerS, SchmalenA, et al.Cell surface profiling of retinal müller glial cells reveals association to immune pathways after LPS stimulation. Cells, 2021; 10(3):711.
23.
LaorobT, NgoenkamJ, NuiyenA, et al.Comparative effectiveness of Nitro dihydrocapsaicin, new synthetic derivative capsaicinoid, and capsaicin in alleviating oxidative stress and inflammation on lipopolysaccharide-stimulated corneal epithelial cells. Exp Eye Res, 2024; 244:109950.
24.
QiaoS, LiW, TsubouchiR, et al.Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264. 7 macrophages. Open-Access Radic Res, 2005; 39(9):995–1003.
25.
Muñoz‐MuñozJ, Garcia‐MolinaF, RosE, et al.Prooxidant and antioxidant activities of rosmarinic acid. Journal of Food Biochemistry, 2013; 37(4):396–408.
26.
CharoensinS, DansakdaS. Modulatory effect of rosmarinic acid on H2O2-induced adaptive glycolytic response in dermal fibroblasts. Molecules, 2023; 28(14):5599.
27.
LiangZ, WuL, DengX, et al.The antioxidant rosmarinic acid ameliorates oxidative lung damage in experimental allergic asthma via modulation of NADPH oxidases and antioxidant enzymes. Inflammation, 2020; 43(5):1902–1912.
28.
YesilirmakN, BukanN, KurtB, et al.Toll-like receptor-4 expression and oxidative stress in ocular rosacea. Mol Vis, 2024; 30:211–218.
29.
JohnsonAC, HeinzelFP, DiaconuE, et al.Activation of toll-like receptor (TLR) 2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci, 2005; 46(2):589–595.
30.
MoonD-O, KimM-O, LeeJ-D, et al.Rosmarinic acid sensitizes cell death through suppression of TNF-α-induced NF-κB activation and ROS generation in human leukemia U937 cells. Cancer Lett, 2010; 288(2):183–191.
31.
WeberCE, LiNY, WaiPY, et al.Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res, 2012; 33(3):311–318.
32.
SaikaS, YamanakaO, OkadaY, et al.TGF beta in fibroproliferative diseases in the eye. Front Biosci (Schol Ed), 2009; 1(1):376–390.
33.
SolimanAM, SimRH, DasS, et al.Therapeutic targeting of inflammatory pathways with emphasis on NLRP3 inflammasomes by natural products: A novel approach for the treatment of inflammatory eye diseases. Curr Med Chem, 2022; 29(16):2891–2912.
34.
YerraVG, NegiG, SharmaSS, et al.Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy. Redox Biol, 2013; 1(1):394–397.
35.
ChaiprasongsukA, PanichU. Role of phytochemicals in skin photoprotection via regulation of Nrf2. Front Pharmacol, 2022; 13:823881.
36.
FangueiroJF, CalpenaAC, ClaresB, et al.Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Int J Pharm, 2016; 502(1–2):161–169.
37.
Vivero-LopezM, SparacinoC, Quelle-RegaldieA, et al.PluronicŪ/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests. Int J Pharm, 2022; 628:122281.
38.
LuoL-J, LaiJ-Y. Epigallocatechin gallate-loaded gelatin-g-poly (N-isopropylacrylamide) as a new ophthalmic pharmaceutical formulation for topical use in the treatment of dry eye syndrome. Sci Rep, 2017; 7(1):9380.
39.
LeiJ, WangL, YangC, et al.Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization. J Control Release, 2024; 376:94–107.
40.
AqilF, MunagalaR, JeyabalanJ, et al.Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett, 2013; 334(1):133–141.
